Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Principal Investigator
Ankle Fractures in Diabetic Patients: A Critical Analysis.
Co-Principal Investigator
Selpercatinib-Induced Hypothyroidism Through Off-Target Inhibition of Type 2 Iodothyronine Deiodinase.
IL-23 inhibitors for moderate-to-severe psoriasis.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
IL-23 inhibitors for moderate-to-severe psoriasis.
IL-23 inhibitors for moderate-to-severe psoriasis. Semin Cutan Med Surg. 2018 Sep; 37(3):158-162.
View in:
PubMed
subject areas
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Dermatologic Agents
Humans
Interleukin-23
Psoriasis
authors with profiles
Kenneth Gordon